(8)Hematologic system hemolytic anemia (5) 6. Laboratory findings (1) ANA (2) anti ds-DNa antibody (3)SM antibod (4)RNP antibody (5,)7. Diagno The 1982 Revised Criteria for Classification of sle (5)8. Management of slE nonsteroidal anti-inflammatory drugs(NSAIDs antimalarials(chloroquine (3) SLE glt ytotoxic drugs(cyclophosphamide) moderate dose Gc Img/kg/d (1)9.P (二)重点和难点 重点SLE的临床表现及诊断标准 难点血清免疫学检测意义及发病机制 point focal point: clinical manifestations of SlE criteria for classification and diagnosis of slemental disorder （7）Digestive system （8）Hematologic system ITP hemolytic anemia （9）eye （5’） 6. Laboratory findings （1）ANA （2）anti ds—DNA antibody （3）SM antibody （4）RNP antibody （5）Antiphospholipid antibody （6）RF （7）Complement （8）Pathology （9）check in device （5’） 7. Diagnosis The 1982 Revised Criteria for Classification of SLE （5’） 8. Management of SLE （1）remove the cause （2）Discoid nonsteroidal anti-inflammatory drugs（NSAIDs + antimalarials (chloroquine） （3）SLE glucocorticoid (GC) + cytotoxic drugs(cyclophosphamide) moderate dose GC 1mg/kg/d （4）progress of therapy （1’） 9. Prognosis (二)重点和难点 重点 SLE 的临床表现及诊断标准 难点 血清免疫学检测意义及发病机制 （二）focal point and difficulty focal point：clinical manifestations of SLE criteria for classification and diagnosis of SLE difficulty： immunology laboratory findings are interpreted by laboratorg analysis pathogenesis